Susan I. Barr, PhD, RDN, FDC, FACSM is Professor of Nutrition at the University of British Columbia. She completed her undergraduate degree at the University of British Columbia, and obtained her PhD in Human Nutrition from the University of Minnesota and the Mayo Clinic. Her research interests focus on cognitive dietary restraint (the perception of constantly limiting food intake), and she has demonstrated important associations among high levels of dietary restraint, menstrual disturbances, and bone health in young women of normal weight.
Rosemary Basson, MD, FRCP (UK) is a Clinical Professor in the Department of Psychiatry at the University of British Columbia. With a background in Internal Medicine and Family Practice, Dr. Basson is the Director of the UBC Program in Sexual Medicine. After some 80-plus peer reviewed articles, many focusing on a reconceptualization of human sex response and on sexual dysfunction in chronic illness, and some 30-plus book chapters Dr. Basson is now focusing CIHR funded clinical research on the management of women's sexual pain as well as on the effects of childhood stress on adult women's sexual function. Her 2012 model of Provoked Vestibulodynia as an example of maladaptive stress response has gained much attention.
Valerie Beral, MD, PhD, Oxford, Professor of epidemiology, Director of the Imperial Cancer Research Fund's cancer epidemiology unit, University of Oxford, Gibson Building, Radcliffe Infirmary, Oxford. Dr. Beral views the research goals of the unit under her direction as identifying ways in which cancers can be prevented.
Marilyn Borugian, PhD, is a research scientist with the Cancer Control Research Program of the British Columbia Cancer Agency and Director of the BC Generations Project. After 25 years as a computer programmer, systems analyst, project manager and teacher in the financial services area of information technology, Marilyn has turned her analytical skills to cancer research, with a special interest in modifiable lifestyle risk factors. She published her Master's thesis on gender differences in colorectal cancer risk factors, and recently published a portion of her PhD dissertation on modifiable lifestyle factors such as body shape, diet, and exercise that have the potential to improve survival in women with breast cancer.
Lori Brotto, PhD is a Professor in the UBC Department of Obstetrics and Gynaecology, and Head of the Division of Gynaecologic Specialties, as well as a registered psychologist in Vancouver, Canada. She holds a Canada Research Chair in Women's Sexual Health (2016-2021). She is the director of the UBC Sexual Health Laboratory where research primarily focuses on developing and testing psychological and mindfulness-based interventions for women with sexual desire and arousal difficulties and women with chronic genital pain. Other major lines of research include exploring psychosocial versus hormonal predictors of women's sexual response, asexuality, sex and cancer, and genital self-image. Dr Brotto is an Associate Editor for the Archives of Sexual Behavior, has over 100 peer-reviewed publications, is the Sexual Health expert writer for the Globe and Mail, and is frequently featured in the media on topics related to sexuality.
Frances Chen PhD is an Assistant Professor of Psychology at the University of British Columbia, a Canadian Institutes of Health Research (CIHR) New Investigator, and the Principal Investigator of the UBC Social Health Lab. She received her Ph.D. from Stanford University and completed an Alexander von Humboldt postdoctoral fellowship at the University of Freiburg, Germany. She investigates how people establish, negotiate, and sustain social relationships. Her research combines approaches from social psychology, health psychology, and neuroendocrinology.
Anthony P. Cheung MBBS MPH MBA is a reproductive endocrinologist and infertility (REI) specialist with 25 years of clinical, research and teaching experience in his field. He holds specialist credentials in Obstetrics and Gynecology in both Australia/New Zealand and Canada with subspecialty training in Menopause in Sydney, Australia and REI in California, USA.
Formerly on academic staff at both the University of Alberta and the University of British Columbia, he was the Medical Director of the UBC IVF programme and is the Founder and Medical Director of Grace Fertility and Reproductive Medicine.
He is a translational scientist with research spanning molecular biology and physiology of the ovary to clinical endocrinology (particularly related to PCOS), and clinical epidemiological studies related to his field of REI. In addition to PCOS and menopause, his research includes metabolomic profiling of human embryo culture media with Raman spectroscopy and sperm parameters in predicting male fertility. His research team is currently examining diet, physical activity, and stress in women with PCOS.
Hélène Côté, PhD is Associate Professor of Pathology and Laboratory Medicine at the University of British Columbia and a member of the UBC Centre for Blood Research and the Women's Health Research Institute. Her training is in biochemistry and molecular biology. Her research program focuses on cellular aging in the context of HIV infection and its treatment. She currently leads the pan-Canadian CARMA cohort study.
Tom Elliot, MBBS, FRCPC, has been a faculty member at the University of British Columbia since 1992 where his current rank is Clinical Associate Professor. He is also Co-Director of Undergraduate Medical Education for the Division of Endocrinology. Dr. Elliott is the former Chair of the Endocrinology & Metabolism Society of BC, the professional body representing all BC endocrinologists and diabetes specialists. Since 1992 Dr. Elliott has been on the active medical staff at Vancouver General Hospital, has conducted a busy private office practice in Internal Medicine, Endocrinology & Diabetology, and maintained an active research and clinical trials program. Dr. Elliott will continue his research program as director of clinical trials at bcdiabetes.ca.
Michelle M. Epstein, MD is an allergist and clinical immunologist at the Medical University of Vienna in Vienna, Austria. Currently, she is a research scientist studying the differentiation and maintenance of T-helper lymphocytes in experimental models of allergic diseases.
Siri Forsmo MD MPH PhD, currently Head of Department at the Dept. of Public Health and General Practice, Norwegian University of Science and Technology, Trondheim, Norway. Her training is in gynaecology & obstetrics, community medicine and public health. Her research is mainly in epidemiology, notably in the fields of female cancer, osteoporosis and fractures, health services and medical technology assessment. She is also involved in several interdisciplinary projects in medical history and bioethics.
Ian S Fraser AO, MD, BSc (Hons), FRANZCOG, FRCOG, CREI, Professor in Reproductive Medicine at the University of Sydney. gained his undergraduate, postgraduate and specialist training at the Universities of Edinburgh and Oxford. He gained specialist qualifications in obstetrics and gynaecology through the Royal College of Obstetricians and Gynaecologists (UK) and through the Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG). He is a certified subspecialist in reproductive endocrinology and infertility, and a past-President of RANZCOG. He is internationally recognised for his research in the fields of menstrual disorders, contraception, menopause and gynaecological endoscopic surgery. He has been appointed an Officer in the Order of Australia for service to medicine in the areas of obstetrics, gynaecology, reproductive endocrinology and family planning as a leading practitioner, researcher and educator, and to the establishment of professional and educational standards.
Michelle Fung, MD, FRCPC, is a clinical assistant professor at the University of British Columbia in the Division of Endocrinology, Department of Medicine. She completed Medical School and Internal Medicine residency at McMaster University, and fellowships in Endocrinology and Clinical Investigator Program at UBC. During that time she completed a Masters in Health Care and Epidemiology and additional fellowship training in Islet Transplantation in Edmonton. She is involved with undergraduate and postgraduate education in the Department of Medicine at UBC. She has been on staff at Vancouver General Hospital and St. Paul's Hospital since 2004.
Karen Gelmon MD FRCPC is a Professor of Medicine at the UBC and a Medical Oncologist at the BCCA, combining clinical and translational research. She is currently Head of the Division of Medical Oncology at UBC. She is Co Chair of the Breast Site Committee for the Canadian Clinical Trials Group, on the IND executive of that organization, and a member of the NCI Breast Steering Committee and of the BIG (Breast International Group) Executive Board. She is also a Komen scholar and member of the Scientific Advisory Council for Komen and Co Chair of the Scientific Advisory Council of the Ontario Institute of Cancer Research. She sits on the International Advisory Board of The Lancet, The Oncologist and Clinical Breast Cancer. She is an active teacher interested in education of health care professionals and the public and has published extensively with over 250 publications. She was the recipient of a YWCA Woman of Distinction award in 2003.
Janet E. Hall,MD, is Clinical Director of the National Institute of Environmental Health Sciences (NIEHS). She was a Professor of Medicine at Harvard Medical School and the Associate Chief of the Reproductive Endocrinology Unit, Endocrine Division, Massachusetts General Hospital. She is an internationally recognized physician-scientist who studies human reproductive physiology and pathophysiology with a view to translating this information to benefit women with reproductive disorders. She has had significant experience helping investigators across disciplines to design translational studies.
The application of her research has helped many women with hypothalamic amenorrhea (HA), polycystic ovarian syndrome (PCOS) and acquired hypogonadotropic hypo-gonadism (AHH) to conceive. Dr. Hall is the Past-President of the Endocrine Society, which has over 17,000 members worldwide. She also has served on numerous NIH Special Emphasis Panels and numerous Editorial Boards.
Carol Herbert BSc. MD is the former Dean of the Schulich School of Medicine & Dentistry at Western University (1999-2010), former Head of UBC Department of Family Practice (1988-98) and has been a member of the Institute Advisory Board for the CIHR Institute of Gender Health.
After practising full-service Family Medicine in Vancouver at REACH from 1971-82, then at UBC Campus Family Practice Teaching Unit until 1999, Dr Herbert moved to Ontario to take up her position as Dean.
She was a pioneer in developing services for sexually abused children and in 1984 co-founded the still-operating Vancouver Sexual Assault Assessment program. She has done participatory research in sexual assault, family violence and clinical health promotion, including projects on diabetes and ecosystem health with Indigenous communities in BC, Ontario, and Africa.
Dr Herbert is a Fellow of the College of Family Physicians of Canada, Fellow and current President of the Canadian Academy of Health Sciences and an International Member of the National Academy of Medicine.
Suzanne C. Ho, BA, MSc, MPH, PhD, is Professor of Community and Family Medicine at the Chinese University of Hong Kong. She is also Director of Postgraduate Programmes in Epidemiology and Biostatistics and Women’s Health Studies. With background in physiology and trained in public health and epidemiology, Suzanne’s research interests are in ageing, women's health, nutritional epidemiology and osteoporosis.
Dr. Patricia Janssen is a Professor and Director of the Master of Public Health Program and Co-theme leader, Maternal Child Health in the School of Population and Public Health at the University of British Columbia. Her areas of Specialty are: Maternal/Fetal/Newborn Health, Women's Health, Population Health, and Clinical Epidemiology/Clinical Trials. She is currently researching; Reducing cesarean section rates in BC, Health trajectories among women leaving prison in BC, Updating standards for intrauterine fetal growth, Impact of exposure to interpersonal violence on pregnancy outcomes, Management of early labour and Outcomes associated with home birth.
Dr. Shirin Kalyan earned her PhD from the University of British Columbia in Experimental Medicine investigating the pivotal mediators of inflammation in the context of toxic shock syndrome. Her research interests include dissecting the pathophysiology of disease rooted in immune dysfunction, especially those that interact with endocrine function(such as osteoporosis and chronic inflammation associated metabolic disturbances). After obtaining her doctorate, Shirin furthered her inter- and cross-disciplinary training with Professor Jerilynn Prior in clinical endocrinology where she studied the role of ovarian hormones in the context of inflammation, oxidative stress, ovulatory disturbances and osteoporosis. Shirin was subsequently awarded a fellowship from the Alexander von Humboldt Foundation to carry out research in Germany on the adverse immune effects of nitrogen-bisphosphonate therapy, the most common treatment of choice for disorders of bone fragility such as osteoporosis and cancer-associated bone disease, which led to her discovery that some of the drug's bizarre rare side effects, such as ostenocrosis of the jaw, were associated with its disruption of immune homeostasis. Whilst away from the lab and research, Shirin can inevitably be found indulging in discussions on the politics of science, the environment, and philosophy and/or her joy in trekking through exotic unscathed locations at high altitudes.
Elaine Kingwell, BSc., MSc., PhD. is a Research Associate in the Division of Neurology, Faculty of Medicine at the University of British Columbia. She is an epidemiologist with a background in behavioural neuroscience and psychology. Her research interests include population health, health risk communication and the effects of bone mineral density testing on health behaviour as well as risk factors associated with multiple sclerosis (MS) and the long-term risks and benefits associated with treatments for MS. In addition to her research projects related to MS, Dr Kingwell has been a co-investigator on studies based at CeMCOR of the influence of exercise on bone fragility and a validation study of a questionnaire related to ovulation.
Yvonne Lamers PhD is Canada Research Chair in Human Nutrition and Vitamin Metabolism (2010-2020) and Assistant Professor in the Food Nutrition and Health Program at The University of British Columbia. Her research focuses on B-vitamin metabolism with the overarching goal to identify biological mechanisms linking nutrition, health, and disease and to evaluate optimal vitamin status to maintain biochemical functions. As evidenced by her recent work, Dr Lamers' goal is to create a translational nutritional research program and contribute new knowledge that can be applied in clinical practice and public health for the benefit of individuals and vulnerable population groups. Dr Lamers' efforts on defining B-vitamin adequacy during early infancy and pregnancy for early diagnosis of fetal deficiencies aim to contribute to the determination of fetal origins of disease and early indicators of disease risk.
France Légaré MD, PhD, CCFP, FCFP practised family medicine in Quebec and is a full professor in Family and Emergency Medicine at Université Laval, Quebec. In 2005, she obtained her PhD in Population Health from the University of Ottawa. The same year, she was awarded a grant as a clinical investigator from the Fonds de la recherche en santé du Québec (FRSQ) for her research program entitled "Health professionals in primary care: From knowledge brokers to decision brokers." From June 2006 to May 2016, Dr. Légaré held the title of Tier 2 Canada Research Chair in Shared Decision Making and Knowledge Translation, junior level. As of June 1st 2016, she holds the title of Tier 1 Canada Research Chair in Shared Decision Making and Knowledge Translation. She was also the Canadian Cochrane Network Site representative at Université Laval (the CHU de Québec Research Centre) from 1999 to 2013 and, from 2013-15, its inaugural scientific director. She now acts as its scientific co-director.
Susan M. Love MD, is an adjunct Clinical Professor of Surgery at the David Geffen School of Medicine at UCLA and the President and Medical Director of the Susan Love MD Breast Cancer Foundation, a non-profit organization dedicated to the eradication of breast cancer. She is one of the founders and a director of the National Breast Cancer Advisory Board. Her research on an intraductal approach to breast cancer led her to found ProDuct Health Inc., a medical device company which was recently acquired bythe Cytyc Health Corporation. She is the author of Dr. Susan Love’s Breast Book and Dr. Susan Love's Hormone Book, and most recently, Dr. Susan Love’'s Menopause and Hormone Book. Although retired from the practice of surgery, she still helps women through LLuminari, a multi-media women’s health content company and http://dslrf.org/.
Heather Macdonald, PhD is Associate Director of Research for the Bone Health Research Group at the University of British Columbia and the Centre for Hip Health and Mobility. She received her PhD from the University of British Columbia in Exercise Science and went on to complete a postdoctoral fellowship in bone imaging at the University of Calgary. Her main research interest is the relationship between physical activity and bone health across the lifespan, with a particular focus on how physical activity affects bone growth and development in healthy and clinical populations as measured using state-of-the-art bone imaging techniques. Heather also has a keen interest in promoting physical activity and healthy living in elementary and secondary schools and has been involved with intervention trials that have led to changes in provincial policies related to school-based physical activity.
Barbara Mintzes, PhD, is a Senior Lecturer in the Faculty of Pharmacy and Charles Perkins Centre at the University of Sydney, Australia, and an Affiliate Associate Professor with the School of Population and Public Health at the University of British Columbia (UBC). She worked with the Therapeutics Initiative, a UBC based research group, from 1999 to 2015, to carry out systematic reviews of the effectiveness and safety of new drugs. Dr Mintzes also researches the effects of drug promotion, including direct-to-consumer advertising of prescription medicines, on prescribing, medicine use and thresholds for disease diagnosis. Dr Mintzes holds a doctorate in epidemiology from UBC. She has also worked for many years with consumer and women’s health organizations, in Canada and internationally.
Millan Patel MD obtained his Medical degree and Masters in Genetics at the University of Alberta and completed residency training in Medical Genetics at the University of Toronto. Millan studied bone physiology in post-doctoral research at Baylor College of Medicine in Houston, Texas. He is a co-founder and Research Director for the Rare Disease Foundation and is a clinical assistant professor in the Department of Medical Genetics at the University of British Columbia. He was the co-director for British Columbia for 7 years of the Canadian Multicentre Osteoporosis Study. His current research includes studies on rare bone disorders, osteoporosis genetics, Adams-Oliver syndrome, CMTC, preterm birth and rare eye disorders.
Maria de Nazaré Pereira has a PhD in the Sociology of Science from the University Research Institute of Rio de Janeiro (IUPERJ). As professor of Information Science at the Brazilian Institute of Science and Technology Information, she oriented dozens of graduate theses in areas such as Communication in Science, Dissemination of Scientific Information, Information and Communication Technology and the Information Society, amongst others. She is currently a Visiting Professor at the Virtual University of the State of Maranhão (UNIVIMA/Brazil), and at the University of Cuenca (Ecuador). She also has wide experience as a consultant, most notably in projects of the World Bank, the Inter-American Development Bank and the Departments of Health and Social Development of the City of São Paulo.
Moira A. Petit BA, MS, PhD. s a co-founder and president of Activ8, Inc. (www.activ8-u.com) a company that supports organizations and communities in creating physically active, healthy and high performing cultures. She received her doctorate in Exercise Physiology from the University of British Columbia in 2000 where she published articles on physical activity, bone health and ovulation. After serving on the faculty at Penn State University, she moved to the University of Minnesota, founding the Laboratory of Musculoskeletal Health (LMH) and was the associate director of the Laboratory of Physiological Hygiene and Exercise Science (LPHES). She became an Associate Professor and received Tenure in 2009. Dr. Petit has published on issues related to sports medicine, health and physical activity with over 50 peer-reviewed journal articles and book chapters.
Sheila M. Pride MD is a reproductive endocrinologist and Clinical Assistant Professor of Gynecology at Vancouver Hospital and the University of British Columbia. She is particularly interested in the clinical care and consequences for women with long-standing anovulatory androgen excess (also known as "polycystic ovarian disease"). She has collaborated with Dr. Jerilynn C. Prior on menstrual cycle research since the early 1980s. Dr. Pride is the co-investigator in a proposed randomized, double blind placebo-controlled study of cyclic progesterone, low dose birth control pills or placebo in symptomatic early perimenopausal women.
Elizabeth Saewyc PhD, RN, PHN. Dr Saewyc is the director of the Stigma and Resilience Among Vulnerable Youth Centre (SARAVYC) and a Professor of Nursing at the University of British Columbia. Her research focuses on health issues of youth, particularly how stigma, violence, and trauma influence teens' health, coping and risk behaviours, and what protective factors in relationships and environments can buffer this trauma for young people. For the past 19 years, she has conducted research with many different groups of vulnerable adolescents, including runaway and street-involved youth, sexually abused and sexually exploited teens, gay/lesbian/bisexual/transgender adolescents, youth in custody, immigrants, home-stay students, and refugees, and indigenous youth in several countries. In addition to sexual health issues, her research focuses on mental health issues such as self-harm and suicide attempts, grief and coping, and substance use/abuse. The majority of her studies have been funded by CIHR or the U.S. National Institutes of Health.
Vanadin Seifert-Klauss, MD, PhD, is assistant professor and head of the working group on gynecological endocrinology and osteoporosis at the Women's Hospital of the Technische Universität München (TUM), where she works as consultant of the gynaecological outpatient policlinic and hormone clinics. Several of her publications deal with longitudinal bone changes across perimenopause, her current research also involves the influence of progesterone on osteoblasts in vitro, effects of ovulation on bone markers in healthy women, as well as bone changes with breast cancer therapies.
Tricia S. Tang BA,PhD, is an associate professor who joined the faculty in the Department of Medicine, Division of Endocrinology at the University of British Columbia in 2011. She completed her undergraduate work at Duke University where she received her B.A. in psychology. After finishing her PhD in clinical psychology, she also trained in behavioural medicine at the University of Chicago and did bio-behavioral breast cancer research at Mount Sinai Medical Center in New York. Before joining UBC, she was on faculty of the Department of Medical Education at the University of Michigan Medical School. She holds many prestigious national research grants. Dr Tang researches innovative psychosocial supports for those with chronic diseases.
Helena J Teede MBBS, FRACP, PhD is the Director of Research for the Jean Hailes Foundation for Women's Health, Professor of Women's Health and Site Director - School of Public Health and Preventative Medicine at Monash University. Dr Hailes is also Head of Diabetes for the Southern Health region in Melbourne, Australia. Her clinical and public health/women's health research focuses on prevention/management of obesity and its complications, especially the impact on reproductive and metabolic women's health. She has a highly competitive clinical, public health research and knowledge translation track record with international recognition.
Ehud Ur MBBS, FRCPC, is a Professor of Medicine at University of British Columbia and Head of the UBC Division of Endocrinology. He is a graduate of the University of London, and trained in medicine and endocrinology at St. Bartholomew's Hospital, London. He came to Canada in 1992 and held faculty positions at Memorial and Dalhousie Universities before moving to Vancouver. Dr. Ur is past Chair of the Canadian Diabetes Association (Clinical and Scientific Section). He is active in research focusing on pituitary, obesity and diabetes-related health issues.
Virginia J. Vitzthum, PhD is a Professor of Anthropology at Indiana University (Bloomington) and Senior Scientist at the Kinsey Institute. In 2011, she was elected a Fellow of the American Association for the Advancement of Science for her research contributions, particularly for evolutionary models of women's reproductive function, and her international work bridging science and policy. Her research focuses on the environmental, behavioral and sociocultural determinants of individual and population variation in women's reproductive functioning and the consequences of this variation for women's health. Her policy contributions include prevention of mother-to-child HIV transmission and improving contraceptive technologies. She has conducted research in the Andes, Central Asia, Europe and the USA. Most recently, with funding from the US National Science Foundation and the Iceland Fulbright Commission, she and her Icelandic collaborators are conducting a multi-season study of the impact of dramatic seasonal changes in photoperiod on several aspects of women's physiology including ovarian and immune functioning, sleep and activity patterns, and psychosocial well-being.
John D. Wark MBBS, PhD, FRACP. Head, Royal Melbourne Hospital Bone and Mineral Service and Broadmeadows Osteoporosis Centre. Dr. Wark is Professor of Medicine at the University of Melbourne, Australia. He has an international reputation in the bone field and is known for his work on vitamin D metabolism; for studying twins of different ages and genders over many years; for the role of physical activity in bone health and for his work with the World Health Organization as a consultant on osteoporosis and menopause. He also works with merino sheep as an animal model of osteoporosis. Sheep are more suitable than many non-primates because they ovulate year-round (like women) rather than sporadically, or once a year.
Monterrey Wigglesworth BScPharm (honours) from the University of British Columbia is a community pharmacist specializing in women’s health, especially with regards to hormones, nutrition and lifestyle. She has worked with pharmacies in the Lower Mainland of British Columbia. She also lived and worked as a pharmacist in New Zealand and has recently returned there to work in Auckland. Monterrey has been trained in the compounding of hormones in Australia and nutritional medicine in the US. Her aim is to provide reputable resources for the public and fellow health professionals as well as network amongst the professions to help educate and validate the safe and effective practice of hormonal and nutritional medicine. Ms. Marks has become known in the pharmacy community and region in which she works, for having expertise in progesterone. She was a co-investigator in CeMCOR’s Community Pharmacists’ Knowledge of Progesterone study.